Urovo Technology's share price decline outpaces its EPS, reflecting market caution. Persistent weakness in share price could be a negative sign, yet contrarian investors may see a turnaround potential.

Investors may face future disappointment due to the company's high P/E ratio and declining earnings. Unless recent medium-term conditions significantly improve, current prices may be unreasonable.

EPS improvement doesn't mirror the share price, suggesting an overestimation of past growth. Despite low yield, the stock price isn't dividend-driven. The price drop seems unjust given revenue growth, indicating potential investment. Urovo Technology's future seems uncertain with a significant annualized TSR loss.